// App-Quantinova.ai

TCT-440 : Two-year Clinical Outcomes Of Primary Stenting Of Totally Occluded Native Coronary Arteries III (PRISON III): A Randomized Comparison Of Sirolimus-Eluting Stent Implantation With Zotarolimus-Eluting Stent Implantation For The Treatment Of Total Coronary Occlusions

Researchers

Presenter

  • Koen Teeuwen

Principal Investigators

  • Ben Van den Branden

  • Jacques Koolen

  • Jose Henriques

  • Jan Tijssen

  • Hans Kelder

  • Rene Van der Schaaf

  • Paul Vermeersch

  • Benno Rensing

  • Maarten J. Suttorp

Medical Centers

  • Amphia hospital, Breda, Netherlands

  • Onze Lieve Vrouwe Gasthuis, Amsterdam, Noord-Holland, Netherlands

  • St Antonius Hospital, Nieuwegein, Netherlands

  • ZNA Middelheim, Antwerp, Belgium

  • Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands

Locations

  • Belgium

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • sirolimus

  • ZoMaxx

  • Rapacan

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved